Pernille Tveden-Nyborg

Pernille Tveden-Nyborg

Associate Professor

Member of:

    ORCID: 0000-0002-5574-5742

    Publication year:
    All
    1 - 4 out of 4Page size: 100
    1. 2024
    2. Published

      CRISPR-Cas9 immune-evasive hESCs are rejected following transplantation into immunocompetent mice

      Frederiksen, Henriette Reventlow S, Glantz, A., Vøls, K. K., Skov, Søren, Tveden-Nyborg, Pernille, Freude, Kristine & Doehn, U., 28 May 2024, In: Frontiers in Genome Editing. 6

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Novel traceable CRISPR-Cas9 engineered human embryonic stem cell line (E1C3 + hSEAP + 2xKO + pCD47), has potential to evade immune detection in pigs

      Frederiksen, Henriette Reventlow S, Skov, Søren, Tveden-Nyborg, Pernille, Freude, Kristine & Doehn, U., 7 May 2024, In: Stem Cell Research.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. E-pub ahead of print

      Validation of computed tomography as a diagnostic tool in guinea pigs with non-alcoholic fatty liver disease

      Lintrup, K., Ipsen, David Højland, Skat-Rørdam, Josephine, Lykkesfeldt, Jens, Tveden-Nyborg, Pernille & Buelund, Lene Elisabeth, 2024, (E-pub ahead of print) In: Laboratory Animals.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Gender balance in the editorial room: BCPT as model journal?

      Wellendorph, Petrine & Tveden-Nyborg, Pernille, 2024, In: Basic and Clinical Pharmacology and Toxicology. 134, 6, p. 767-769

      Research output: Contribution to journal › Editorial › Research › peer-review

    ID: 4225698